PRMT7 anticorps (N-Term)
Aperçu rapide pour PRMT7 anticorps (N-Term) (ABIN632137)
Antigène
Voir toutes PRMT7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- PRMT7 antibody was raised against the N terminal of PRMT7
-
Purification
- Affinity purified
-
Immunogène
- PRMT7 antibody was raised using the N terminal of PRMT7 corresponding to a region with amino acids MKIFCSRANPTTGSVEWLEEDEHYDYHQEIARSSYADMLHDKDRNVKYYQ
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PRMT7 Blocking Peptide, (ABIN5615569), is also available for use as a blocking control in assays to test for specificity of this PRMT7 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PRMT7 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PRMT7 (Protein Arginine Methyltransferase 7 (PRMT7))
-
Autre désignation
- PRMT7
-
Sujet
- Arginine methylation is an apparently irreversible protein modification catalyzed by arginine methyltransferases, such as PMT7, using S-adenosylmethionine (AdoMet) as the methyl donor. Arginine methylation is implicated in signal transduction, RNA transport, and RNA splicing.
-
Poids moléculaire
- 78 kDa (MW of target protein)
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Antigène
-